Pacalis Therapeutics Pty

Company snapshot

Pacalis Therapeutics is a privately held, neuroscience-driven biotechnology company focused on the optimization and development of next-generation therapies targeting prevalent mental health disorders. Named after the Latin word for "peaceful", Pacalis is committed to addressing the substantial unmet medical need in mental health, with approximately 1 in 8 individuals worldwide affected by these c

• 1 approved product(s) across US/EU regulatory metadata.
• 5 active pipeline program(s) linked via ClinicalTrials.gov.
• 5 trial update(s) in the last 12 months.

Public regulatory, clinical, patent, and corporate records for Pacalis Therapeutics Pty. Not investment advice.

Recent activity

Latest pipeline, patent, and corporate events for Pacalis Therapeutics Pty.

1. Jun 8, 2026 Clinical update

   Cipaglucosidase Alfa — Phase 3

2. Jun 8, 2026 Clinical update

   Migalastat Hydrochloride Dispersible Tablet — Phase 3

3. May 26, 2026 Clinical update

   AT2221 — Phase 3

4. May 26, 2026 Clinical update

   migalastat HCl 150 mg — Phase 3

5. May 26, 2026 Clinical update

   AT2221, ATB200 — Phase 3

View all clinical trial activity →

• What is Pacalis Therapeutics Pty?

  AMICUS THERAPEUTICS PTY is a pharma organization headquartered in AU. Primary therapeutic focus areas include Pompe Disease (Late-onset), Fabry Disease, Fabry disease. NovaPharmaNews links 5 clinical program(s), 1 drug profile(s), and 0 patent record(s) to this entity from public

• Is Pacalis Therapeutics Pty publicly traded?

  Pacalis Therapeutics Pty appears in our database through regulatory marketing authorisation or clinical trial sponsor records; a US listed ticker is not shown for this entity.

• What drugs does Pacalis Therapeutics Pty develop or market?

  We link 6 drug profile(s) where Pacalis Therapeutics Pty is an originator or marketer in FDA or regional approval metadata. See the drug portfolio table on https://novapharmanews.com/companies/amicus-therapeutics-europe-limited#company-drugs.

• What are the latest developments for Pacalis Therapeutics Pty?

  In the last 12 months our linked public records show 5 trial program update(s) and 0 US patent grant(s) tied to this profile.

• What therapeutic areas does Pacalis Therapeutics Pty focus on?

  Pacalis Therapeutics Pty focuses on Pompe Disease (Late-onset), Fabry Disease, Fabry disease based on our analysis of their pipeline programs and drug development activities.